Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations

JAMA Intern Med. 2016 Apr;176(4):546-7. doi: 10.1001/jamainternmed.2015.7901.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Advisory Committees
  • Aged
  • Early Detection of Cancer / statistics & numerical data*
  • Guideline Adherence / statistics & numerical data*
  • Humans
  • Kallikreins / blood*
  • Male
  • Middle Aged
  • Physicians, Primary Care
  • Practice Guidelines as Topic*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Preventive Medicine
  • Primary Health Care / statistics & numerical data*
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • United States
  • Urology / statistics & numerical data*

Substances

  • Kallikreins
  • kallikrein-related peptidase 3, human
  • Prostate-Specific Antigen